Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. August 2016 11:00 ET | Quelle: Aequus Pharmaceuticals

Aequus Announces Advancement of Anti-Nausea Transdermal Extended-Release Patent Application

VANCOUVER, BC--(Marketwired - August 05, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on...
29. Juli 2016 09:57 ET | Quelle: Aequus Pharmaceuticals

Aequus Announces Advancement of Clobazam Transdermal Patent Application

VANCOUVER, BC--(Marketwired - July 29, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on...
22. Juli 2016 17:30 ET | Quelle: Aequus Pharmaceuticals

Aequus Appoints Ann Fehr as Chief Financial Officer

VANCOUVER, BC--(Marketwired - July 22, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or "Company") today announced Ann Fehr is joining the growing specialty...
02. Mai 2016 21:00 ET | Quelle: Aequus Pharmaceuticals

Aequus Announces Stock Option Grant

VANCOUVER, BC--(Marketwired - May 02, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company") announced today it has granted incentive stock options to...
28. April 2016 09:23 ET | Quelle: Aequus Pharmaceuticals

Aequus Pharmaceuticals Initiates Promotional Efforts for VISTITAN(TM) in Canada

VANCOUVER, BC--(Marketwired - April 28, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company") announced today that it has initiated commercial...
26. April 2016 11:45 ET | Quelle: Aequus Pharmaceuticals

Aequus to Present at Bloom Burton & Co. Healthcare Investor Conference

VANCOUVER, BC--(Marketwired - April 26, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on...
26. Februar 2016 13:29 ET | Quelle: Aequus Pharmaceuticals Inc.

Aequus Awarded Growth Stage Life Sciences Company of the Year

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 26, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE:AQS)(OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company...
16. Februar 2016 09:00 ET | Quelle: Aequus Pharmaceuticals Inc.

Aequus Licenses Canadian Commercialization Rights to Trokendi XR(R) and Oxtellar XR(R) From Supernus

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 16, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE:AQS)(OTCQB:AQSZF) ("Aequus" or the "Company") announced today that it has entered...
04. Februar 2016 12:21 ET | Quelle: Aequus Pharmaceuticals Inc.

Aequus Announces Positive Results From Single-Dose Bioavailability Study of Aripiprazole Transdermal Patch

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Feb. 4, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE:AQS)(OTCQB:AQSZF) ("Aequus" or the "Company"), announced today positive results from...
18. Januar 2016 10:30 ET | Quelle: Aequus Pharmaceuticals Inc.

Aequus Pharmaceuticals to Present at Noble Capital Markets' Investor Conference

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Jan. 18, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE:AQS)(OTCQB:AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company...

Vorherige Seite